At the news
? NEUTRALIMPACT 2/10 144 filed Jun 15, 2026 at 17:59 ET
Officer Stephen Michael Kelsey filed a Form 144 notice of intent to sell 4,071 shares of Revolution Medicines common stock, valued at approximately $626,000. The shares were acquired through restricted stock unit grants in 2023-2025, and the sale appears to be a routine diversification or tax-related transaction. Given the negligible size relative to RVMD's $32.7B market cap, this filing carries no material signal for the stock.
- Insider Stephen Michael Kelsey (officer) filed Form 144 to sell 4,071 shares of RVMD common stock.
- Estimated market value of proposed sale: ~$626,405 based on filing date.
- Shares were acquired via RSU grants on 03/01/2023, 03/01/2024, and 03/01/2025 for services rendered.
- Prior sale of 4,302 shares occurred on 03/17/2026 for ~$427,965.
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access